Bladder Cancer

Early Recurrence After Laparoscopic Radical Cystectomy Explored

Early Recurrence After Laparoscopic Radical Cystectomy Explored

During first 24 months, 8.7% of patients with favorable pathological characteristics had progressed.

Gender Differences in Chemotherapy for Stage IV Bladder Cancer

Gender Differences in Chemotherapy for Stage IV Bladder Cancer

Women with stage IV bladder cancer have a lower median overall survival rate when compared to men.

Immunotherapy Helps Advanced Bladder Cancer Patients

Immunotherapy Helps Advanced Bladder Cancer Patients

About a quarter of older patients deemed too frail for chemo responded to atezolizumab.

Achieving 4 Lifestyle Standards May Reduce Cancer Mortality

Achieving 4 Lifestyle Standards May Reduce Cancer Mortality

Four key lifestyle factors include weight, exercise, no smoking, and limiting alcohol.

Drug Cleared for Refractory Advanced Bladder Cancer

Drug Cleared for Refractory Advanced Bladder Cancer

By

Atezolizumab received accelerated FDA approval for patients whose disease has progressed despite platinum-based chemotherapy.

Leisure Activity Linked With Lower Risk of Several Cancers

Leisure Activity Linked With Lower Risk of Several Cancers

Findings for self-reported leisure-time physical activity of moderate to vigorous intensity.

Prostate, Bladder Cancer Linked to BPH

Prostate, Bladder Cancer Linked to BPH

By

In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.

Pioglitazone Use, Bladder Cancer Linked

Pioglitazone Use, Bladder Cancer Linked

By

Bladder cancer risk increases with longer duration of use.

CKD Is a Risk Factor for UTUC

CKD Is a Risk Factor for UTUC

By

Researchers found elevated incidences of upper tract urothelial carcinoma (UTUC) in patients with CKD.

Cytoreductive RC Aids Survival of Metastatic Bladder Cancer Patients

Cytoreductive RC Aids Survival of Metastatic Bladder Cancer Patients

By

Patients who underwent debulking had significantly longer overall survival compared with those who did not (median 15.7 vs 10 months).

Neoadjuvant Chemo Rarely Used in Upper Tract Urothelial Cancer

Neoadjuvant Chemo Rarely Used in Upper Tract Urothelial Cancer

By

Therapy used in less than 5% of cases, even in those with higher clinical stage.

Bladder Preservation Therapy for MIBC Predicts Worse Survival

Bladder Preservation Therapy for MIBC Predicts Worse Survival

By

Mortality risk decreases with increasingly stringent BPT compared with radical cystectomy.

Surgeons Performing More Radical Cystectomies Robotically

Surgeons Performing More Radical Cystectomies Robotically

By

This approach is associated with less need for blood transfusions versus open surgery, but short-term outcomes, including mortality, are similar.

Key Micronutrients Lacking in Black Bladder Cancer Survivors' Diets

Key Micronutrients Lacking in Black Bladder Cancer Survivors' Diets

By

African American survivors had lower intakes of 8 select micronutrients, such as folate, compared with Caucasian survivors.

Bladder Cancer Risk Higher Following Prostate Radiotherapy

Bladder Cancer Risk Higher Following Prostate Radiotherapy

By

The increased risk occurs more than 10 years after treatment and most pronounced in men who undergo brachytherapy.

Gender Differences Found in Bladder Cancer Treatment, Survival

Gender Differences Found in Bladder Cancer Treatment, Survival

By

Cancer-specific survival at 5 years was 76.9% for men and 71.5% for women.

Pre-Cystectomy Chemo Does Not Hike C. Difficile Risk

Pre-Cystectomy Chemo Does Not Hike C. Difficile Risk

By

New study also reveals no significant association between infection and use of proton pump inhibitors and peri-operative antibiotic redosing.

Well Water Linked to Bladder Cancer

Well Water Linked to Bladder Cancer

Researchers believe arsenic exposure might contribute to higher-than-normal rates.

Well-Timed Follow-Up Reduces Post-Cystectomy Readmissions

Well-Timed Follow-Up Reduces Post-Cystectomy Readmissions

The timing of office visits and telephone calls helped identify a patient at risk for readmission post-radical cystectomy.

New Bladder Cancer Guidelines Released

New Bladder Cancer Guidelines Released

By

Recommendations for diagnosing and managing non-muscle invasive bladder cancer promise to allow for more individualized patient care.

Cutaneous Ureterostomy a Good Alternative for Elderly RC Patients

Cutaneous Ureterostomy a Good Alternative for Elderly RC Patients

By

Shorter operating time is one advantage of cutaneous ureterostomy with a single stoma.

Afatinib Shows Promise for Metastatic Urothelial Carcinoma

Afatinib Shows Promise for Metastatic Urothelial Carcinoma

By

Median time to progression or drug discontinuation was 6.6 months in patients with specific genetic alterations, compared with 1.4 months in other patients.

Pioglitazone May Increase Bladder Cancer Risk

Pioglitazone May Increase Bladder Cancer Risk

Duration- and dose-response associations for pioglitazone; no correlation for rosiglitazone.

ASCO Endorses European Guideline on Bladder Cancer

ASCO Endorses European Guideline on Bladder Cancer

The guidelines were assessed for developmental rigor, and the ASCO endorsed all but one of the guidelines.

Bladder Cancer, Hypothyroidism Linked to Agent Orange

Bladder Cancer, Hypothyroidism Linked to Agent Orange

Vietnam veterans have an increased risk of bladder cancer and hypothyroidism due to exposure to Agent Orange.

Readmission Due to Infection After Bladder Surgery Linked to Smoking

Readmission Due to Infection After Bladder Surgery Linked to Smoking

By

Current smoking is independently associated with a greater than 2-fold increased odds of hospital readmission after radical cystectomy.

Bladder Cancer Patient Frailty Predicts Radical Cystectomy Outcomes

Bladder Cancer Patient Frailty Predicts Radical Cystectomy Outcomes

By

The more risk factors patients have, the greater their risk of serious perioperative complications.

Post-Cystectomy VTE Common, Risky

Post-Cystectomy VTE Common, Risky

By

Patients with venous thromboembolism tended to die earlier from their bladder cancer.

Rosiglitazone May Up Bladder Cancer Risk

Rosiglitazone May Up Bladder Cancer Risk

Exclusive rosiglitazone use is associated with 3-fold increased odds of bladder cancer.

Finasteride May Lower Bladder Cancer Risk in Men

Finasteride May Lower Bladder Cancer Risk in Men

By

The likelihood of being diagnosed with the malignancy was 37% lower in men who used the 5ɑ-reductase inhibitor than those who did.

Sign Up for Free e-newsletters